Inrig Jula (CIK 0001902368)

Latest company ownership

TVTX - Travere Therapeutics, Inc.
Role: CHIEF MEDICAL OFFICER
Shares held
88,787
Last filed at
Jul 2, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 1, 2025 Jul 2, 2025 Travere Therapeutics, Inc. CHIEF MEDICAL OFFICER Sell 51.3 -815 -0.91% ✓ $11.9K
Feb 10, 2025 Feb 12, 2025 Travere Therapeutics, Inc. CHIEF MEDICAL OFFICER Sell 42.5 -2,568 -2.79% ✗ $60.4K
Jan 31, 2025 Feb 4, 2025 Travere Therapeutics, Inc. CHIEF MEDICAL OFFICER Sell 95.0 +24,727 41.60% ✓ $106.1K
Jan 3, 2025 Jan 6, 2025 Travere Therapeutics, Inc. CHIEF MEDICAL OFFICER Sell 41.3 -2,506 -4.05% ✓ $47.7K
Sep 10, 2024 Sep 10, 2024 Travere Therapeutics, Inc. CHIEF MEDICAL OFFICER Sell 50.0 -684 -1.09% ✓ $8.9K
Sep 5, 2024 Sep 9, 2024 Travere Therapeutics, Inc. CHIEF MEDICAL OFFICER Sell 86.3 +4,559 7.85% ✗ $25.2K
Jan 31, 2024 Feb 2, 2024 Travere Therapeutics, Inc. CHIEF MEDICAL OFFICER Sell 91.3 +22,826 64.76% ✗ $18.5K
Jan 3, 2024 Jan 5, 2024 Travere Therapeutics, Inc. Chief Medical Officer Sell 36.3 -2,509 -6.65% ✓ $23.6K
Jan 4, 2023 Jan 6, 2023 Travere Therapeutics, Inc. Chief Medical Officer Sell 25.0 -2,493 -12.47% ✓ $51.7K